Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in Man
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemic subjects were fed diets in which dietary fat calories were held constant, but carbohydrate calories were varied. Three subjects with fasting chylomicronemia (Type V) were given less carbohydrate and four subjects without fasting chylomicronemia (Type IV) were fed diets with more calories as carbohydrate. The restricted carbohydrate intake led to disappearance of chylomicronemia in those subjects who had chylomicronemia on a normal diet (Type V to IV). In those subjects without chylomicronemia, chylomicronemia appeared in response to increased carbohydrate intake (Type IV to V). Thus chylomicron concentrations in plasma were altered even though fat intake and presumably chylomicron input into plasma was kept constant. These findings provide evidence for saturation of chylomicron removal mechanisms by alteration of endogenous triglyceride-rich lipoprotein concentrations. They suggest that chylomicrons compete with very low density lipoproteins for similar removal mechanisms. The relationship between endogenous triglyceride concentration and the lipolytic activity in plasma following heparin was then evaluated with the use of long-term heparin infusions to release and maintain lipolytic activity in the circulation. 10 subjects were placed on fatfree diets to remove circulating dietary fat. The plasma lipolytic rate during the heparin infusion was measured consecutively on different days in individuals whose triglyceride concentrations were varied by either increasing or decreasing calories. The lipolytic rate was curvilinearly related to the plasma triglyceride concentrations. This curvilinear relationship followed Michaelis-Menton saturation kinetics over a wide range of triglyceride concentrations on fat-free, high-carbohydrate diets, in multiple studies in a group of individuals. These studies suggest that endogenous and exogenous triglyceride compete for a common, saturable, plasma triglyceride removal system related to lipoprotein lipase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with severe or very severe triglyceride levels (Ն1000 mg/dl), the LpL removal system is saturated (74).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Factors that reduce VLDL clearance can raise triglyceride concentrations in those with high baseline levels (eg, usually Ͼ500 mg/dL, because of the competition of VLDL and chylomicrons for a common saturable removal mechanism).97”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [97]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, chylomicrons compete with endogenous VLDL for the action of LPL [20].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Electrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
Editorial: A System for Phenotyping Hyperlipoproteinemia
FREDRICKSON, D. S., & LEES, R. S. (1965) · Circulation · doi:10.1161/01.cir.31.3.321 · Cited by 507
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Lipolytic activity of post-heparin plasma in hyperglyceridemia
Fredrickson, D. S., Ono, K., & Davis, L. L. (1963) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40361-x · Cited by 370
Havel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336
The Metabolic Basis of Inherited Disease
Martin, D. B. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300020128027 · Cited by 320
Classification of Hyperlipidemias and Hyperlipoproteinemias
(1972) · Circulation · doi:10.1161/01.cir.45.2.501 · Cited by 257
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma
Reaven, G. M., Hill, D. B., Gross, R. C., & Farquhar, J. W. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105290 · Cited by 221
Research works printed but not linked: 2
- [10]10. Boberg, J. 1971. Mechanisms of hypertriglyceridemia in man. Thesis. Acta Universitatis Upsaliensis, Uppsala, Sweden.
- [19]19. Snedecor, G. W., and W. G. Cochran. 1967. Statistical Methods. The Iowa State University Press, Ames. 6th edition. 456.
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“This phenomenon may take place by elevated levels of FFA [72], which are generated by the action of LPL mediated lipolysis.”
BackgroundInfluentialFish oils and plasma lipid and lipoprotein metabolism in humans: a critical review
Harris, W. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38310-3 · Cited by 1,127
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“Clearance of VLDL from the circulation is reduced in many patients with hypertriglyceridemia (64, 65, 73), in part due to saturation of triglyceride clearance (74).”
Self-citationAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
Goodnight, S. H., Harris, W. S., Connor, W. E., & Illingworth, D. R. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.2.87 · Cited by 683
Pathophysiology of Diabetic Dyslipidemia
Hirano, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17023 · Cited by 552
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531
“increased levels of VLDL that compete with chylomicrons for LPL-mediated lipolysis (10,11).”
BackgroundMerkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Krauss, R. M., Levy, R. I., & Fredrickson, D. S. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107855 · Cited by 437
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418
Mechanisms for the acute effect of fructose on postprandial lipemia
Chong, M. F.-F., Fielding, B. A., & Frayn, K. N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.6.1511 · Cited by 368
“Thus, despite the minor contribution of de novo fatty acids to the overall increase of VLDL-TG by fructose, the effect of fructose on lipid metabolism may be con- siderable.”
InfluentialPostprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348
“Chylomicrons (48) and lipid emulsions (49) are cleared more slowly in patients with elevated VLDL concentrations (likely because of increased competition for LPL), and reductions in endogenous VLDL concentrations accelerate chylomicron clearance (50).”
BackgroundHealth consequences of visceral obesity
Després, J.-P. (2001) · Annals of Medicine · doi:10.3109/07853890108995963 · Cited by 334
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331
“It is known that exogenous and endogenous triglyceride-rich lipoproteins compete for the same clearance mechanism (63).”
BackgroundThomsen, C., Rasmussen, O., Lousen, T., Holst, J. J., Fenselau, S., Schrezenmeir, J., & Hermansen, K. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1135 · Cited by 325
“Thus, after the butter meal, an excessive increase in VLDL particles superimposed on chylomicrons could contribute to the augmented triacylglycerol concentrations (42), exceeding the capacity of the common triacylglycerol removal mechanism for chylomicron and VLDL particles (46, 47).”
BackgroundOsborne, J. C., & Brewer, H. B. (1977) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60220-x · Cited by 285
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
CHAIT, A., ALBERS, J. J., & BRUNZELL, J. D. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00004.x · Cited by 277
Self-citationStanhope, K. L., & Havel, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2b24a · Cited by 269
Redgrave, T. G., & Carlson, L. A. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40633-9 · Cited by 256
Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248
Preferential Uptake of Dietary Fatty Acids in Adipose Tissue and Muscle in the Postprandial Period
Bickerton, A. S. T., Roberts, R., Fielding, B. A., Hodson, L., Blaak, E. E., Wagenmakers, A. J. M., Gilbert, M., Karpe, F., & Frayn, K. N. (2007) · Diabetes · doi:10.2337/db06-0822 · Cited by 246
Berman, M., Hall, M., Levy, R. I., Eisenberg, S., Bilheimer, D. W., Phair, R. D., & Goebel, R. H. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41575-5 · Cited by 244
Chahil, T. J., & Ginsberg, H. N. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.002 · Cited by 233
Sugars, hypertriglyceridemia, and cardiovascular disease
Fried, S. K., & Rao, S. P. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.873s · Cited by 232
“Because the high-sugars diets increase concentrations of VLDL, these particles may compete for hydrolysis by lipoprotein lipase, which delays the clearance of chylomicrons and accounts for their presence in fasted serum (19).”
BackgroundMetabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe, F., Steiner, G., Olivecrona, T., Carlson, L. A., & Hamsten, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116293 · Cited by 230
Lipid abnormalities in uremia, dialysis, and transplantation
Chan, M. K., Varghese, Z., & Moorhead, J. F. (1981) · Kidney International · doi:10.1038/ki.1981.62 · Cited by 227
Triglycerides and Heart Disease: Still a Hypothesis?
Goldberg, I. J., Eckel, R. H., & McPherson, R. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226100 · Cited by 219
Chylomicron clearance in normal and hyperlipidemic man
Grundy, S. M., & Mok, H. Y. I. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80006-6 · Cited by 218
Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion
Sparks, J. D., & Sparks, C. E. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90088-4 · Cited by 222
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Watts, G. F., Rosenson, R. S., Hegele, R. A., Goldberg, I. J., Gallo, A., Mertens, A., Baass, A., Zhou, R., Muhsin, M., Hellawell, J., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2409368 · Cited by 215
Gender Difference in Postprandial Lipemia: Importance of Visceral Adipose Tissue Accumulation
Couillard, C., Bergeron, N., Prud’homme, D., Bergeron, J., Tremblay, A., Bouchard, C., Mauriège, P., & Després, J.-P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2448 · Cited by 216
Després, J.-P. (1994) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80289-7 · Cited by 205
LEWIS, G. F., O'MEARA, N. M., SOLTYS, P. A., BLACKMAN, J. D., IVERIUS, P. H., PUGH, W. L., GETZ, G. S., & POLONSKY, K. S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-934 · Cited by 202
Frayn, K. N., Williams, C. M., & Arner, P. (1996) · Clinical Science · doi:10.1042/cs0900243 · Cited by 204
Hypertriglyceridemia secondary to obesity and diabetes
Subramanian, S., & Chait, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.003 · Cited by 200
Secondary causes of hyperlipidemia.
Stone, N. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30179-1 · Cited by 199
Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man.
Crouse, J. R., & Grundy, S. M. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37800-7 · Cited by 201
Lipoprotein lipase: physiology, biochemistry, and molecular biology
Goldberg, I. (2001) · Frontiers in Bioscience · doi:10.2741/goldberg · Cited by 194
Frayn, K. N., Shadid, S., Hamlani, R., Humphreys, S. M., Clark, M. L., Fielding, B. A., Boland, O., & Coppack, S. W. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.3.e308 · Cited by 188
Duez, H., Lamarche, B., Uffelman, K. D., Valero, R., Cohn, J. S., & Lewis, G. F. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000222015.76038.14 · Cited by 187
Bjorkegren, J., Packard, C. J., Hamsten, A., Bedford, D., Caslake, M., Foster, L., Shepherd, J., Stewart, P., & Karpe, F. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37637-9 · Cited by 187
Postprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182
Molecular pathobiology of the human lipoprotein lipase gene
Murthy, V., Julien, P., & Gagné, C. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00005-8 · Cited by 179
Hazzard, W. R., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90149-9 · Cited by 169
Self-citationPostprandial lipoprotein metabolism: VLDL vs chylomicrons
Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 168
“Certain pools of CMremnants have a very long residence time, at least as long as similarsized VLDL particles [24,25].”
BackgroundWilson, D. E., Emi, M., Iverius, P. H., Hata, A., Wu, L. L., Hillas, E., Williams, R. R., & Lalouel, J. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114770 · Cited by 165
Gill, J. M. R., & Hardman, A. E. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00275-9 · Cited by 159
“hydrolysis of lipoprotein-TG by lipoprotein lipase (LPL) residing on the capillary endothelium of extra-hepatic tissues, particularly adipose tissue and skeletal muscle [6,7].”
BackgroundA Disorder of Muscle Lipid Metabolism and Myoglobinuria: Absence of Carnitine Palmityl Transferase
Bank, W. J., DiMauro, S., Bonilla, E., Capuzzi, D. M., & Rowland, L. P. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502272920902 · Cited by 159
Hypertriglyceridemia in the genomic era: a new paradigm
Lewis, G. F., Xiao, C., & Hegele, R. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1062 · Cited by 152
Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity
Herd, S. L., Kiens, B., Boobis, L., & Hardman, A. E. (2001) · Metabolism · doi:10.1053/meta.2001.24199 · Cited by 181
Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.199 · Cited by 143
Juliano, R. L. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90004-x · Cited by 142
Lipoprotein metabolism and its relationship to atherosclerosis
Ginsberg, H. N. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30174-2 · Cited by 136
Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen
KUSHWAHA, R. S., HAZZARD, W. R., GAGNE, C., CHAIT, A., & ALBERS, J. J. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-517 · Cited by 138
Self-citationGrundy, S. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.28 · Cited by 133
Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr, F., & Kern, F. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37744-0 · Cited by 131
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Crouse, J. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90692-9 · Cited by 130
Matikainen, N., Söderlund, S., Björnson, E., Pietiläinen, K., Hakkarainen, A., Lundbom, N., Taskinen, M., & Borén, J. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13487 · Cited by 129
“Intestinal-derived chylomicron remnants and liver-derived VLDL remnants are cleared from the circulation by common pathways and, therefore, compete for clearance.(10) Increased secretion of VLDL from the liver is, therefore, an important predictor of postprandial accumulation of chylomicron remnants.”
BackgroundReduction in postprandial lipemia after walking: influence of exercise intensity
TSETSONIS, N. V., & HARDMAN, A. E. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199610000-00005 · Cited by 129
Chait, A., & Eckel, R. H. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0203 · Cited by 128
Kirkpatrick, C. F., Sikand, G., Petersen, K. S., Anderson, C. A. M., Aspry, K. E., Bolick, J. P., Kris-Etherton, P. M., & Maki, K. C. (2023) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2023.05.099 · Cited by 118
Grosskopf, I., Baroukh, N., Lee, S.-J., Kamari, Y., Harats, D., Rubin, E. M., Pennacchio, L. A., & Cooper, A. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000186189.26141.12 · Cited by 128
Hogue, J.-C., Lamarche, B., Tremblay, A. J., Bergeron, J., Gagné, C., & Couture, P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600548-jlr200 · Cited by 129
Cohn, J. S., McNamara, J. R., & Schaefer, E. J. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.12.2456 · Cited by 125
“The decrease in LDL-C was probably caused by (a) diminished conversion of VLDL to LDL, owing to saturation of the lipolytic process (13) and increased direct uptake of VLDL remnants; (b) alteration in the cholesterol ester content of LDL, owing to postprandial changes in the activity of cholesterol ester transfer prot…”
BackgroundWeintraub, M. S., Rosen, Y., Otto, R., Eisenberg, S., & Breslow, J. L. (1989) · Circulation · doi:10.1161/01.cir.79.5.1007 · Cited by 127
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 127
“This is consistent with concomitant upregulation of hepatic LDL receptor with inhibition of intestinal cholesterol absorption (49) and competition for removal between apoB-48- and apoB-100-containing particles (25).”
BackgroundImpaired chylomicron remnant clearance in familial combined hyperlipidemia.
Cabezas, M. C., de Bruin, T. W., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.804 · Cited by 125
“'(41) This has been explained by the common lipolytic route for VLDLs and chylomicrons.(24) The present findings support this mechanism, since a 54% reduction in plasma TG concentration in FCH subjects resulted in a 39% improvement of chylomicron remnant RP removal.”
BackgroundResultInfluentialSanders, T. A. B., Oakley, F. R., Miller, G. J., Mitropoulos, K. A., Crook, D., & Oliver, M. F. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3449 · Cited by 123
A Comprehensive Update on the Chylomicronemia Syndrome
Goldberg, R. B., & Chait, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.593931 · Cited by 117
“This provides support for the notion that the pathophysiological disturbances in triglyceride metabolism that accompany diabetes can interact with polygenic forms of HTG to result in triglyceride levels that exceed the saturation point for triglyceride removal from plasma (47), thereby leading to severe HTG and the MF…”
BackgroundSigurdsson, G., Nicoll, A., & Lewis, B. (1976) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1976.tb00508.x · Cited by 121
Palmquist, D. L., & Mattos, W. (1978) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(78)94410-7 · Cited by 119
“Increasing either concentration ( 3 ) or particle size (15) of triglyceride-rich lipoproteins increases their clearance rate from serum.”
BackgroundDuez, H., Lamarche, B., Valéro, R., Pavlic, M., Proctor, S., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Circulation · doi:10.1161/circulationaha.107.739888 · Cited by 115
NICOLL, A., & LEWIS, B. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb02090.x · Cited by 115
Prolonged Exercise Augments Plasma Triglyceride Clearance
Sady, S. P. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380180114030 · Cited by 114
Halkes, C. J. M., van Dijk, H., de Jaegere, P. P. T., Plokker, H. W. M., van der Helm, Y., Erkelens, D. W., & Castro Cabezas, M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095276 · Cited by 112
GILL, J. M. R., FRAYN, K. N., WOOTTON, S. A., MILLER, G. J., & HARDMAN, A. E. (2001) · Clinical Science · doi:10.1042/cs1000517 · Cited by 109
Harris, W., & Muzio, F. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.1.68 · Cited by 105
TSETSONIS, N. V., & Hardman, A. E. (1996) · European Journal of Applied Physiology · doi:10.1007/bf00334418 · Cited by 126
The effect of a single bout of brisk walking on postprandial lipemia in normolipidemic young adults
Aldred, H. E., Perry, I., & Hardman, A. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90263-1 · Cited by 121
Musliner, T. A., Herbert, P. N., & Kingston, M. J. (1979) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(79)90029-8 · Cited by 102
Acquired Hyperlipidemia (Secondary Dyslipoproteinemias)
Chait, A., & Brunzell, J. D. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30324-4 · Cited by 112
Self-citationPostprandial lipemia and chylomicron clearance in athletes and in sedentary men
Cohen, J. C., Noakes, T. D., & Benadé, A. J. S. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.3.443 · Cited by 97
Karpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 102
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Kumari, A., Kristensen, K. K., Ploug, M., & Winther, A.-M. L. (2021) · Biomedicines · doi:10.3390/biomedicines9070782 · Cited by 116
“The hydrolysis takes place at the luminal face of the capillary endothelium where LPL hydrolyzes the triglycerides within the neutral cores of chylomicrons and VLDLs producing chylomicron remnants and IDLs, respectively (Figure 1) [16].”
BackgroundPHENOTYPE STUDY OF APOLIPOPROTEIN E ISOFORMS IN HYPERLIPOPROTEINAEMIC PATIENTS
Ghiselli, G., Zech, L., Gregg, R., Schaefer, E., & Brewer, H. B. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90439-1 · Cited by 93
Reduced oxidation of dietary fat after a short term high-carbohydrate diet
Roberts, R., Bickerton, A. S. T., Fielding, B. A., Blaak, E. E., Wagenmakers, A. J. M., Chong, M. F., Gilbert, M., Karpe, F., & Frayn, K. N. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.824 · Cited by 92
“The clearance of VLDL-triacylglycerol is suppressed by the presence of chylomicrons in the postprandial state, because chylomicrons are the better substrate for lipoprotein lipase (6, 24).”
BackgroundMenopause Is Associated With Reduced Protection From Postprandial Lipemia
van Beek, A. P., de Ruijter-Heijstek, F. C., Erkelens, D. W., & de Bruin, T. W. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.11.2737 · Cited by 93
Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia
Stalenhoef, A. F. H., Casparie, A. F., Demacker, P. N. M., Stouten, J. T. J., Lutterman, J. A., & Laar, A. V. (1981) · Metabolism · doi:10.1016/0026-0495(81)90072-x · Cited by 91
Long-term kinetic study of β-carotene, using accelerator mass spectrometry in an adult volunteer
Dueker, S. R., Lin, Y., Buchholz, B. A., Schneider, P. D., Lamé, M. W., Segall, H. J., Vogel, J. S., & Clifford, A. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31972-6 · Cited by 99
Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk
Otarod, J. K., & Goldberg, I. J. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0043-4 · Cited by 99
“At plasma TG levels of more than 500 mg/dL, LPL actions are saturated, leading to defects in clearance of both VLDL and chylomicrons [ 15 ].”
BackgroundPlasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease
Maranhão, R. C., Feres, M. C., Martins, M. T., Mesquita, C. H., Toffoletto, O., Vinagre, C. G. C., Gianinni, S. D., & Pileggi, F. J. C. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05889-3 · Cited by 95
Brunzell, J. D., Porte, D., & Bierman, E. L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90089-1 · Cited by 86
Self-citationChylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics
Julve, J., Martín-Campos, J. M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.004 · Cited by 118
“pathway in a competitive manner [83], but CMs seem to be the preferred substrate of lipoprotein lipase [84].”
BackgroundPostprandial hyperlipidemia: another correlate of the “hypertriglyceridemic waist” phenotype in men
Blackburn, P., Lamarche, B., Couillard, C., Pascot, A., Bergeron, N., Prud’homme, D., Tremblay, A., Bergeron, J., Lemieux, I., & Després, J. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.06.001 · Cited by 98
“Competition of apo B-48 and apo B-100 containing TRLs for LPL during the postprandial period could be responsible, at least in part, for the prolonged accumulation of TRLs [35] especially considering the fact that, in our study, post-heparin LPL activity was the lowest among men with “hypertriglyceridemic waist”.”
BackgroundTinker, L. F., Parks, E. J., Behr, S. R., Schneeman, B. O., & Davis, P. A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.6.1126 · Cited by 83
Metadata
- Authors
- Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Brunzell, John D.
- Venue
- Journal of Clinical Investigation
- Published
- 1973-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1578-1585
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC302428
- OpenAlex
- W2077829695
- Cited by
- 484
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 3 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 6
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- VLDL, triglyceride-rich lipoproteins, lipoprotein lipase, Michaelis-Menten kinetics, carbohydrate intake, dietary fat, heparin infusion, lipolysis
- MeSH terms
- Adult, Chylomicrons, Dietary Carbohydrates, Dietary Fats, Female, Heparin, Humans, Hydrolysis, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Male, Middle Aged, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.